Lilly CEO Is Optimistic on Cancer, Diabetes Drugs

July 24 (Bloomberg) -- John Lechleiter, chief executive officer of Eli Lilly & Co., talks with Bloomberg's Olivia Sterns about the company's second-quarter results, drugs and growth strategy. Lilly raised its full-year forecast after second-quarter sales grew faster than expected and cost-cutting programs took effect. (Source: Bloomberg)

Greenspan Says Trump's Budget 'Arithmetic' Is Wrong
40:00 - Former Federal Reserve Chairman Alan Greenspan talks about President Trump's proposed tax and spending plans. He speaks to Bloomberg's David Westin on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • What Is Shaping the Global Oil Market?
  • Rep. Crowley Says Trump’s First 100 Days Was Disastrous
  • Oaktree’s Marks on Trump Tax Plan and Corporate Credit